RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth
Has this study been replicated?
The atlas records 1 replication of this study. Recorded outcomes: 1 failed.
Replications
- Replication Study: RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth, Pelech et al. (2021). Outcome recorded: failed.
"The original study reported analogous results with GDC-0879, which was not observed in this replication."
View paper
Other studies in the atlas
Failed replications · Successful replications · All browse pages